# American Antibiotics, Inc., Baltimore, MD – FDA Inspections

Source: https://www.keypedia.com/companies/american-antibiotics-inc/2eea05ce-c683-45c9-afeb-a9c1ef59c6ca

> Inspection records and compliance data for American Antibiotics, Inc. in Baltimore, Maryland. 3 FDA inspections on record, 1 warning letter, last inspected December 19, 2014.

---

## Details

- Name: American Antibiotics, Inc.
- FEI Number: 3005425963
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: 6110 Robinwood Rd
- City: Baltimore
- State: Maryland
- Zip Code: 21225
- Country Name: United States
- Address: 6110 Robinwood Rd, Baltimore, Maryland 21225, United States
- Country: United States

## Related Documents

- [EIR - American Antibiotics, Inc. - 2015-12-18](https://www.keypedia.com/records/eir/american-antibiotics-inc/7243f26f-953e-4712-8b03-e312f43affc0) — source: FDA, date: December 18, 2015
- [FDA Inspection 909130 - American Antibiotics, Inc. - 2014-12-19](https://www.keypedia.com/records/fda_inspections/american-antibiotics-inc/cee0abc5-de4d-4062-8007-29786c687130) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 19, 2014
- [WARNING_LETTER - American Antibiotics, Inc. - 2014-07-23](https://www.keypedia.com/records/warning_letter/american-antibiotics-inc/d8e5409f-43b5-4f98-b4ba-b2569c0027e2) — source: FDA, date: July 23, 2014
- [EIR - American Antibiotics, Inc. - 2013-03-28](https://www.keypedia.com/records/eir/american-antibiotics-inc/2c5fdea3-2ce9-4989-9153-caf5c21a4308) — source: FDA, date: March 28, 2013
- FDA Inspection 823964 - American Antibiotics, Inc. - 2013-03-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 28, 2013
- FDA Inspection 740386 - American Antibiotics, Inc. - 2011-08-19 — classification: No Action Indicated (NAI), source: FDA, date: August 19, 2011

## Related Companies

- [Reveragen Biopharma Inc.](https://www.keypedia.com/companies/reveragen-biopharma-inc/eaf70eaf-05c9-4025-b737-094553dcf19f)
- [Michael J. Polydefkis, M.D.](https://www.keypedia.com/companies/michael-j-polydefkis-md/f67f7603-94b9-4cb8-a7c5-90751ac1dce1)
- [Wanzhu Hou, CMD, MD (CN)](https://www.keypedia.com/companies/wanzhu-hou-cmd-md-cn/e1608fee-f767-4781-98f2-bc27db2520e2)
- [Leadiant Biosciences, Inc.](https://www.keypedia.com/companies/leadiant-biosciences-inc/96da3cf1-2605-43f0-b819-2daa4c14e527)
- [Medicine Invention Design Incorporation IRB](https://www.keypedia.com/companies/medicine-invention-design-incorporation-irb/e44eb96d-12cf-40b4-bad0-077b64ce61fd)
- [PAREXEL Early Phase Clinical Unit](https://www.keypedia.com/companies/parexel-early-phase-clinical-unit/9748c7f3-64a9-490d-994d-e02b56d9d1d0)
- [John J. Wroblewski, M.D.](https://www.keypedia.com/companies/john-j-wroblewski-md/152a4c6a-a7f1-43ad-a4ab-ab9c6b949452)
- [Warner Graham LLLP](https://www.keypedia.com/companies/warner-graham-lllp/b7f7ddcd-3aa8-4189-8732-9a854956ce5f)
- [Tae H. Chung, M.D.](https://www.keypedia.com/companies/tae-h-chung-md/a30fcc9e-9af9-4eaf-ada7-d66551d9318e)
- [Antoine E.  Azar, M.D.](https://www.keypedia.com/companies/antoine-e-azar-md/0cc668e0-7c97-45a8-8d94-bb01fde6aba1)

## Related Officers

- [Senior Advisor](https://www.keypedia.com/people/rachel-c-harrington/254a4217-8cd8-4a79-bf24-9345d34d0550)
- [recipient](https://www.keypedia.com/people/mandeep-k-taneja/4f1da01c-416c-47a4-96c6-9fdbbc844946)
- [Michael M. Levy](https://www.keypedia.com/people/michael-m-levy/3e0fdd21-e691-406d-81cf-4fe2460a6309)
- [company_representative](https://www.keypedia.com/people/arun-sharma/1c02246b-7a0c-4bcf-97dc-2349db1c81ff)
- [Cheryl A. Clausen](https://www.keypedia.com/people/cheryl-a-clausen/2306b2bc-8f01-4f77-ba2d-1a3186d6f6fc)
